CN108191747A — 一种Abemaciclib中间体的制备方法
Assigned to INSTITUTE OF DAFENG MARINE INDUSTRY NANJING UNIVERSITY OF TECHNOLOGY · Expires 2018-06-22 · 8y expired
What this patent protects
本发明公开了一种Abemaciclib中间体的制备方法,属于医药化工领域。本发明的制备方法,通过先后还原5‑(4‑乙基哌嗪‑1‑羰基)‑2‑硝基吡啶的羰基和硝基,从而得到Abemaciclib中间体5‑(4‑乙基‑脈嗓‑1‑基甲基)‑吡啶‑2‑基胺,该方法所用原料和试剂容易获得,反应条件温和,避免使用有毒、有刺激性和强腐蚀性试剂,绿色环保,制备简单易操作,所得产品具有高收率和高纯度,特别适合工业化生产。
USPTO Abstract
本发明公开了一种Abemaciclib中间体的制备方法,属于医药化工领域。本发明的制备方法,通过先后还原5‑(4‑乙基哌嗪‑1‑羰基)‑2‑硝基吡啶的羰基和硝基,从而得到Abemaciclib中间体5‑(4‑乙基‑脈嗓‑1‑基甲基)‑吡啶‑2‑基胺,该方法所用原料和试剂容易获得,反应条件温和,避免使用有毒、有刺激性和强腐蚀性试剂,绿色环保,制备简单易操作,所得产品具有高收率和高纯度,特别适合工业化生产。
Drugs covered by this patent
- Verzenio (abemaciclib) · Eli Lilly
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.